The findings from the late-breaking research presented at the 66th American Society of Hematology (ASH) Annual Meeting and Exposition have brought new insights into the treatment of mantle cell lymphoma (MCL). The phase 3 study EA4151, conducted by the ECOG-ACRIN Cancer Research Group, investigated
New research conducted by the Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine has revealed a significant connection between accelerated aging and an increased risk of early-onset colorectal cancer. This groundbreaking study sheds light on the importance of
The relationship between dietary fructose, particularly from high-fructose corn syrup, and cancer growth is a topic of growing concern. Over the past few decades, the consumption of high-fructose corn syrup has skyrocketed. While naturally occurring fructose in fruits, vegetables, and honey is
Researchers at the Perelman School of Medicine at the University of Pennsylvania have made a significant breakthrough in personalized medicine and cancer treatment. By using patient-derived glioblastoma (GBM) organoids, they have developed a method to model patient responses to CAR-T cell therapy
Certis Oncology Solutions has introduced a groundbreaking innovation: the CertisOI Assistant™, an AI-powered chatbot aimed at significantly enhancing the efficiency of preclinical oncology research. Leveraging the capabilities of artificial intelligence, machine learning (AI/ML), and OpenAI’s
Recent advances in the fight against non-small cell lung cancer (NSCLC) have brought new hope for patients carrying KRAS mutations, thanks to a breakthrough discovery by researchers at UT Southwestern Harold C. Simmons Comprehensive Cancer Center. This advancement revolves around the repurposing of
